COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 463

Article download: 250

Indian Journal of Pharmacy and Pharmacology


Anti-Cancer potentials of the plant Aquilaria malaccensis leaves


Full Text PDF Share on Facebook Share on Twitter


Author Details : Karunakar Hegde*, Fathima Jazeela M A, Vijetha Poojary K, Satish S

Volume : 5, Issue : 3, Year : 2018

Article Page : 135-140


Suggest article by email


Abstract

In the present study the ethanolic extract of Aquilaria malaccensis (Agar wood) leaves before inoculation (BF) and after inoculation (AF)) was evaluated for its anticancer potentials. The leaf extracts (BF and AF) was subjected to in-vitro cytotoxicity studies on EAC cells, normal spleen cells and DLA cells. The leaf extracts showed dose dependent cytotoxicity with increase in dose. The IC50 value for BF and the AF leaf extract was 79.09?g/ml and 79.20?g/ml respectively. The effect on primary spleen cells was observed to be more than 100?g/ml. The study concluded that the extract of the said plant leaves has significant potential anti-cancer activity. All these results clearly indicate that the crude extract has a remarkable capacity to inhibit the growth of Ascites tumor induced by EAC cell line in animals.

Keywords: Anti-cancer, Aquilaria malaccensis, EAC cell line.

Doi : 10.18231/2393-9087.2018.0029

How to cite : Hegde K, Fathima Jazeela M A, Vijetha Poojary K, Satish S, Anti-Cancer potentials of the plant Aquilaria malaccensis leaves. Indian J Pharm Pharmacol 2018;5(3):135-140

Copyright © 2018 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)